Fair Game: EpiPen Price Rises Could Mean More Riches for Mylan Executives

Filings show that under a one-time stock grant created in 2014, top executives stand to reap riches at least partly on the back of price increases on the EpiPen.

from NYT > Health http://ift.tt/2bM42q5
via health&fitness